YOLFTbeta
Compumedics Ltd

Compumedics Ltd

CMP · AU · Healthcare / Medical Devices

0.245AUD+0.01 (+2.08%)

Price History

Full chart

Market Stats

Previous Close0.24
Open0.245
Day Range0.245 – 0.245
52-Week Range0.215 – 0.45
Volume4.08K
Market Cap51.94M
P/E (TTM)0.00
Forward P/E14.37
EPS0.00
Dividend Yield0.00%
Beta0.36
50-Day Avg0.2397
200-Day Avg0.2851

About

Compumedics Limited engages in the research, development, manufacture, and distribution of medical equipment and related technologies in the Americas, Australia, the Asia Pacific, Europe, and the Middle East. It provides sleep diagnostics products, including Somfit/Somfit Pro, a wearable device for collecting patients' physiological data; Somté PSG; Grael PSG; Grael 4K PSG; Falcon PSG; Falcon HST; and Somté, an investigative tool. The company also offers neurology diagnostics, such as ONsight A.V.S. for monitoring patient's home ambulatory studies; Grael 4K PSG:EEG, Grael 4K-EEG, and Grael LT EEG System amplifiers; Neuvo 64-512 Channel LTM EEG monitoring systems; Okti, a portable EEG amplifier; and Siesta 802, a multi-functional ambulatory recording device. In addition, it provides software products, such as Profusion Sleep software suite; Profusion EEG Software; Profusion neXus 360, a web-based patient data and lab management system that offers integrated hardware and software solutions for sleep and neurology clinics; CURRY, a signal processing and source localization multi-modal neuroimaging suite; Profusion neXus Scheduler for planning for staff and time; Somte and Persyst Software; HD Digital Video; Profusion Plus; ECG Free software; and TCM5 FLEX Transcutaneous Monitor, Grael DC, Siesta extended battery pack, and Summit IP products. Further, the company offers magnetoencephalography systems; brain research technologies; pharmaceutical clinical trials and research services; and consumables and supplies for diagnostic and research solutions. Additionally, the company provides doppler diagnostic products; Nuevo LTM EEG; Orion LifeSpan MEG; and quik-cap EEG electrode arrays. The company was incorporated in 1987 and is headquartered in Abbotsford, Australia. Compumedics Limited is a subsidiary of D & DJ Burton Holdings Pty Ltd.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEODr. David Burton Ph.D.
  • Employees175
  • Headquarters30-40 Flockhart Street, Abbotsford, VIC, Australia, 3067, Australia
  • Websitehttps://www.compumedics.com.au

Leadership

  • Dr. David Burton Ph.D.Founder, Executive Chairman & CEO · b. 1959
  • Mr. David Francis LawsonCFO, Company Secretary & Executive Director · b. 1965
  • Mr. Warwick FreemanChief Technology Officer
  • Dr. Kerry Trent HubickLegal Counsel and Trademark, Patent & General Legal Attorney
  • Mr. Michael StoneChief Commercial Officer - US operations

Financials

Income Statement

Currency: AUD1998-06-301999-06-302000-06-302001-06-302002-06-302003-06-302004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Revenue--9.00M16.64M19.75M32.06M33.96M38.50M38.88M36.87M38.58M38.18M32.61M31.27M27.91M27.15M29.07M33.49M37.54M34.42M37.00M41.51M35.07M35.74M37.76M42.41M49.72M51.04M60.25M
Growth (%)---+84.84%+18.68%+62.33%+5.95%+13.36%+0.98%-5.16%+4.64%-1.04%-14.59%-4.13%-10.71%-2.74%+7.06%+15.23%+12.09%-8.33%+7.51%+12.17%-15.51%+1.91%+5.64%+12.32%+17.24%+2.66%+18.05%
Cost of Revenue--3.02M5.13M7.92M14.17M14.58M17.86M18.02M15.38M16.57M16.20M13.27M13.17M14.10M13.33M14.55M15.45M17.61M15.37M15.81M16.74M17.06M16.58M18.44M20.82M23.65M20.05M29.27M
Gross Profit---16.64M11.82M18.27M19.38M20.29M20.85M21.49M22.01M21.98M19.34M18.10M13.82M13.82M14.51M18.04M19.93M19.05M21.19M24.77M18.01M19.16M19.32M21.59M26.07M30.99M30.98M
Gross Margin---100.00%59.87%56.99%57.07%52.71%53.64%58.28%57.04%57.56%59.30%57.88%49.50%50.90%49.93%53.86%53.08%55.35%57.26%59.68%51.36%53.61%51.17%50.91%52.43%60.71%51.41%
Operating Expense---17.82M13.74M38.61M17.29M24.22M23.15M19.99M21.55M19.09M18.95M19.41M16.79M14.69M12.93M15.36M16.72M17.63M18.61M20.23M18.77M18.76M19.18M25.12M26.88M30.27M29.19M
Operating Income-120.00K1.97M-118.00K-1.18M-1.92M-20.34M2.09M-3.93M-2.29M1.50M460.00K2.88M384.00K-1.31M-2.97M-868.00K1.58M2.69M3.21M1.42M2.58M4.54M-756.00K398.00K137.00K-3.53M-812.00K714.00K1.79M
Operating Margin---1.31%-7.11%-9.72%-63.46%6.17%-10.20%-5.90%4.06%1.19%7.55%1.18%-4.19%-10.65%-3.20%5.45%8.02%8.55%4.12%6.96%10.94%-2.16%1.11%0.36%-8.33%-1.63%1.40%2.97%
EBITDA1.38M1.97M-118.00K4.22M-429.00K-367.00K3.14M-2.35M-7.00K1.45M1.95M3.69M1.53M602.00K-156.00K342.00K2.97M4.06M4.85M2.70M4.18M5.78M-5.42M2.56M3.31M-5.05M2.79M1.94M3.98M
EBITDA Margin---1.31%25.38%-2.17%-1.14%9.24%-6.11%-0.02%3.93%5.05%9.66%4.69%1.93%-0.56%1.26%10.21%12.12%12.91%7.84%11.29%13.92%-15.45%7.17%8.77%-11.92%5.61%3.80%6.61%
Net Income788.00K1.22M-95.00K1.97M-1.90M-18.56M2.40M-3.90M-1.59M123.00K756.00K2.73M414.00K81.00K-2.83M-1.49M909.00K1.97M3.27M1.30M2.78M4.02M-5.84M998.00K1.36M-6.12M-338.00K-1.27M214.00K
Net Income Margin---1.06%11.85%-9.61%-57.89%7.06%-10.12%-4.10%0.33%1.96%7.14%1.27%0.26%-10.13%-5.48%3.13%5.88%8.72%3.79%7.52%9.68%-16.65%2.79%3.59%-14.44%-0.68%-2.49%0.36%
R&D--270.00K871.22K2.85M6.71M6.50M7.88M7.31M4.60M4.59M4.87M4.88M4.70M4.63M4.37M5.16M4.76M5.75M5.88M5.11M5.32M3.84M4.39M4.06M5.46M5.74M1.13M4.75M
R&D as % of Total Revenue--3.00%5.24%14.45%20.93%19.14%20.48%18.81%12.48%11.89%12.74%14.95%15.04%16.60%16.09%17.74%14.20%15.31%17.09%13.80%12.82%10.96%12.28%10.74%12.88%11.55%2.22%7.89%
Interest Expense21.00K111.00K158.00K239.00K102.03K187.00K268.00K549.00K643.00K871.00K714.00K560.00K533.00K414.00K515.00K414.00K611.00K675.00K405.00K312.00K207.00K261.00K420.00K330.00K401.00K652.00K739.00K1.28M1.51M
Interest Expense % of Total Revenue--1.76%1.44%0.52%0.58%0.79%1.43%1.65%2.36%1.85%1.47%1.63%1.32%1.84%1.52%2.10%2.02%1.08%0.91%0.56%0.63%1.20%0.92%1.06%1.54%1.49%2.52%2.51%

Balance Sheet

Currency: AUD1998-06-301999-06-302000-06-302001-06-302002-06-302003-06-302004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Assets--34.46M39.20M43.62M23.76M24.51M24.55M22.18M19.25M20.14M21.46M21.81M23.10M19.88M19.09M19.52M21.68M26.12M29.23M34.65M38.66M35.53M38.55M41.71M41.18M40.36M54.39M56.63M
Total Liabilities--4.39M7.03M13.40M12.09M10.56M15.20M15.46M12.34M11.63M9.98M9.62M10.35M10.66M10.73M10.36M10.41M11.53M9.18M11.49M11.34M13.73M16.39M18.12M22.89M22.15M32.57M33.92M
Total Equity--30.07M32.16M30.23M11.68M13.95M9.35M6.72M6.91M8.51M11.48M12.20M12.76M9.21M8.35M9.16M11.27M14.60M20.05M23.16M27.32M21.79M22.16M23.59M18.29M18.21M21.82M22.71M
Cash--13.11M11.45M8.53M5.37M6.35M3.92M3.32M363.00K571.00K2.61M1.84M1.15M1.10M1.29M1.05M2.23M3.07M4.10M3.91M4.60M6.41M6.77M7.29M3.80M1.89M2.69M6.15M
Total Debt--1.68M1.53M8.41M5.24M4.01M5.94M6.44M3.45M2.76M2.50M1.94M2.75M2.08M2.34M2.02M2.00M2.58M715.00K1.89M1.59M4.80M5.82M6.55M9.47M8.58M13.88M14.11M
Net Debt---11.43M-9.92M-123.00K-129.00K-2.35M2.01M3.13M3.08M2.19M-105.00K108.00K1.60M983.00K1.05M963.00K-228.00K-489.00K-3.39M-2.02M-3.01M-1.61M-950.00K-746.00K5.67M6.69M11.19M7.96M

Cash Flow

Currency: AUD1998-06-301999-06-302000-06-302001-06-302002-06-302003-06-302004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Operating Cash Flow---893.11K97.33K2.96M2.63M-366.59K-1.38M847.00K1.86M4.57M454.00K-263.00K1.38M409.00K686.00K2.20M2.23M864.00K559.00K5.14M5.38M1.32M3.29M49.00K2.00M681.00K6.61M
Investing Cash Flow-957.00K-1.24M-932.00K-3.72M-5.37M-5.41M-2.96M-3.67M-112.00K-873.00K-1.84M-2.02M-1.22M-1.08M-523.00K-647.00K-700.00K-1.28M-1.54M-1.29M-2.02M-4.29M-4.23M-1.55M-2.98M-4.41M-2.99M-7.37M-3.90M
Financing Cash Flow-460.00K617.00K3.95M14.57M2.36M-710.00K1.30M1.11M478.00K-2.82M616.00K12.00K-300.00K117.00K-1.07M338.00K-200.00K534.00K-199.00K1.96M1.15M149.00K448.00K-179.00K1.61M-1.00M-1.49M6.10M4.26M
Capital Expenditure957.00K1.24M1.79M353.00K373.00K4.74M669.00K345.00K112.00K957.00K1.84M2.02M1.22M1.08M523.00K334.00K285.00K393.00K304.00K148.00K208.00K1.31M4.23M1.55M2.98M4.41M2.99M214.00K181.00K
Free Cash Flow-957.00K-1.24M-1.79M540.11K-275.67K-4.74M1.96M-711.59K-1.49M-110.00K22.00K2.55M-767.00K-1.34M853.00K75.00K401.00K1.81M1.93M716.00K351.00K3.82M1.15M-230.00K302.00K-4.36M-986.00K467.00K6.42M
Dividends Paid100.00K173.00K394.00K4.20M---700.00K----------00---------
FCF to OCF---60.48%-283.24%-160.25%74.56%194.11%108.13%-12.99%1.18%55.78%-168.94%510.27%61.99%18.34%58.45%82.15%86.38%82.87%62.79%74.42%21.36%-17.37%9.19%-8896.10%-49.28%68.58%97.26%
Dividend Paid to FCF-10.45%-14.01%-21.96%777.58%----98.37%----------0.00%0.00%---------

Earnings

Report DateFeb 25, 2016Sep 27, 2016Feb 28, 2017Sep 18, 2017Feb 26, 2018Aug 29, 2018Feb 26, 2019Sep 1, 2019Mar 1, 2020Aug 30, 2020Feb 24, 2021Aug 30, 2021Feb 22, 2022Sep 30, 2022Feb 28, 2023Feb 28, 2025Sep 30, 2025Feb 26, 2026
EPS Estimate0.000.000.000.000.000.000.000.000.000.000.00-0.00--0.000.00-
EPS Actual0.010.010.000.010.000.010.010.020.00-0.030.010.010.000.01-0.04-0.010.000.10
Surprise------------------
Timing-------------After-hoursAfter-hours--Pre-market

Key Statistics & Ratios

Market Cap51.94M
Enterprise Value55.91M
Trailing P/E0.00
Forward P/E14.37
PEG Ratio1.80
Price / Sales0.84
Price / Book2.11
EPS0.00
Book Value0.141
Revenue (TTM)61.88M
Gross Profit (TTM)32.64M
EBITDA3.77M
Profit Margin0.41%
Operating Margin4.91%
Return on Equity1.14%
Return on Assets3.85%
Shares Outstanding199.76M
Shares Float71.99M
Beta0.36
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20041×
0.01Nov 23, 2004